Finn AV - Search Results

1

Monoclonal Autoantibody Against a Cryptic Epitope on Tissue-Adherent Low-Density Lipoprotein for Molecular Imaging in Atherosclerosis.

Khamis RY, Hartley A, Caga-Anan M, Pandey SS, Marceddu C, Kojima C, Chang SH, Boyle JJ, Johnson JL, Björkbacka H, Guo L, Finn AV, Virmani R, Nilsson J, Haskard DO. Khamis RY, et al. Among authors: finn av. JACC Cardiovasc Imaging. 2022 Aug;15(8):1458-1470. doi: 10.1016/j.jcmg.2022.02.023. Epub 2022 May 13. JACC Cardiovasc Imaging. 2022. PMID: 35926905 Free article.

2

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Joner M, et al. Among authors: finn av. J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5. J Am Coll Cardiol. 2006. PMID: 16814667 Free article.

3

Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.

Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Gold HK, Virmani R. Joner M, et al. Among authors: finn av. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):182-9. doi: 10.1161/01.ATV.0000251021.28725.e8. Epub 2006 Oct 26. Arterioscler Thromb Vasc Biol. 2007. PMID: 17068283

4

Vascular responses to drug eluting stents: importance of delayed healing.

Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Finn AV, et al. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10. doi: 10.1161/ATVBAHA.107.144220. Epub 2007 May 17. Arterioscler Thromb Vasc Biol. 2007. PMID: 17510464 Review.

5

Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?

Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R. Kolodgie FD, et al. Among authors: finn av. J Am Coll Cardiol. 2007 May 29;49(21):2093-101. doi: 10.1016/j.jacc.2006.10.083. Epub 2007 May 17. J Am Coll Cardiol. 2007. PMID: 17531658 Free article. Review.

6

Vascular pathology of drug-eluting stents.

Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Among authors: finn av. Herz. 2007 Jun;32(4):274-80. doi: 10.1007/s00059-007-2997-9. Herz. 2007. PMID: 17607533 Review.

7

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.

Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R. Nakazawa G, et al. Among authors: finn av. Am J Cardiol. 2007 Oct 22;100(8B):36M-44M. doi: 10.1016/j.amjcard.2007.08.020. Am J Cardiol. 2007. PMID: 17950831 Review.

8

Drug-eluting stent pathology--should we still be cautious?

Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Among authors: finn av. Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):1. doi: 10.1038/ncpcardio1093. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18094669 No abstract available.

9

Drug-eluting stent safety: findings from preclinical studies.

Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, Virmani R. Nakazawa G, et al. Among authors: finn av. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1379-91. doi: 10.1586/14779072.6.10.1379. Expert Rev Cardiovasc Ther. 2008. PMID: 19018691 Review.

10

A review of current devices and a look at new technology: drug-eluting stents.

Nakazawa G, Finn AV, Kolodgie FD, Virmani R. Nakazawa G, et al. Among authors: finn av. Expert Rev Med Devices. 2009 Jan;6(1):33-42. doi: 10.1586/17434440.6.1.33. Expert Rev Med Devices. 2009. PMID: 19105778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page